The Record header image

Forward to a friend  |  Subscribe  |  The Record Archive  |  Contacts  |  bcbsm.com  |  Print this article

May 2024

Changes coming to coverage of some prescription drugs

Starting July 1, 2024, we’re changing how we cover some medications on the drug lists associated with our prescription drug plans. The following list detail these changes.

We’ll notify affected members, their groups and their health care providers in writing about the changes, see below for more information.

Drugs that will have a higher copayment

Unless noted, both the brand name and available generic equivalents of the following drugs won’t be covered. If a member fills a prescription for one of these drugs on or after July 1, 2024, they’ll be responsible for the full cost.

The brand-name drug that will have a higher copayment is listed along with suggested, covered preferred alternatives that have similar effectiveness, quality and safety. When pharmacies fill prescriptions with preferred alternatives, the generic equivalents are dispensed, if available. Additional coverage requirements may apply for preferred alternatives.

Drug that will have a higher copayment**

Common use or 
drug class

Preferred alternatives

Ajovy®

Migraine prevention

Aimovig®, Emgality® 120mg/mL

**Nonpreferred brand drugs are not covered for members with a closed benefit.

No portion of this publication may be copied without the express written permission of Blue Cross Blue Shield of Michigan, except that BCBSM participating health care providers may make copies for their personal use. In no event may any portion of this publication be copied or reprinted and used for commercial purposes by any party other than BCBSM.

*CPT codes, descriptions and two-digit numeric modifiers only are copyright 2023 American Medical Association. All rights reserved.